[Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction].

@article{Carlo1997MyocardialRI,
  title={[Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction].},
  author={Mario De Carlo and Aldo Domenico Milano and G C Borzoni and Stefano Pratali and Cosimo Guglielmi and Chiara Barzaghi and Giuseppe Tartarini and Mario Mariani and Uberto Bortolotti},
  journal={Cardiologia},
  year={1997},
  volume={42 5},
  pages={481-8}
}
In this study we evaluated the outcome of coronary artery bypass grafting (CABG) in patients with coronary artery disease and left ventricular dysfunction. The aim of the study was to identify the risk factors for operative and medium-term mortality. We evaluated 117 consecutive patients (98 men, 19 women, aged 42 to 84 years, mean 65 +/- 9) with ejection fraction (EF) < 40%, operated on from January 1994 to December 1995. Patients who had previously undergone CABG, or who had other procedures… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
5% ; 65 patients ( 56% ) had angina and 62 ( 53% ) had congestive heart failure in NYHA functional class III and IV .
5% ; 65 patients ( 56% ) had angina and 62 ( 53% ) had congestive heart failure in NYHA functional class III and IV .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
5% ; 65 patients ( 56% ) had angina and 62 ( 53% ) had congestive heart failure in NYHA functional class III and IV .
5% ; 65 patients ( 56% ) had angina and 62 ( 53% ) had congestive heart failure in NYHA functional class III and IV .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
5% ; 65 patients ( 56% ) had angina and 62 ( 53% ) had congestive heart failure in NYHA functional class III and IV .
5% ; 65 patients ( 56% ) had angina and 62 ( 53% ) had congestive heart failure in NYHA functional class III and IV .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
[ Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction ] .
[ Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction ] .
[ Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction ] .
[ Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction ] .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
5% ; 65 patients ( 56% ) had angina and 62 ( 53% ) had congestive heart failure in NYHA functional class III and IV .
5% ; 65 patients ( 56% ) had angina and 62 ( 53% ) had congestive heart failure in NYHA functional class III and IV .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
[ Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction ] .
[ Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction ] .
[ Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction ] .
[ Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction ] .
[ Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction ] .
[ Myocardial revascularization in patients with ischemic cardiomyopathy and left ventricular dysfunction ] .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
In this study we evaluated the outcome of coronary artery bypass grafting ( CABG ) in patients with coronary artery disease and left ventricular dysfunction .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
Myocardial revascularization in patients with coronary artery disease and left ventricular dysfunction is characterized by low operative risk and good survival rate at 2 years , with improvement of both angina and congestive heart failure .
All Topics